RecruitingNCT05894668

Perioperative Parameter and Treatment Outcomes of ECIRS in Asia

A Prospective Assessment of the Perioperative Parameter and Treatment Outcomes of Endoscopic Combined Intrarenal Surgery (ECIRS) in Asia


Sponsor

Chinese University of Hong Kong

Enrollment

1,000 participants

Start Date

Aug 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

This is an observational, international, multicenter, cohort study, prospectively collecting clinical data registry on consecutive patients with urinary stone undergoing ECIRS.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Patients with urinary calculi
  • Undergoing Endoscopic Combined Intrarenal Surgery (ECIRS)
  • Agreed to consent for the study

Exclusion Criteria3

  • Patients who have ECIRS for other conditions, such as urothelial cancer etc.
  • Patients who intraoperative record was incomplete.
  • Patients only have either PCNL or ureteroscopy done (not both)

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERECIRS

Endoscopic Combined Intrarenal Surgery


Locations(3)

Alice Ho Miu Ling Nethersole Hospital

Hong Kong, Hong Kong

Prince of Wales Hospital

Shatin, Hong Kong

North District Hospital

Sheung Shui, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05894668


Related Trials